{
    "1665587416218976258": {
        "author_id": "194037150",
        "created_at": "2023-06-05T05:12:39.000Z",
        "edit_history_tweet_ids": [
            "1665587416218976258"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 5,
                    "normalized_text": "PRESS",
                    "probability": 0.3429,
                    "start": 1,
                    "type": "Other"
                },
                {
                    "end": 18,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.6455,
                    "start": 7,
                    "type": "Organization"
                },
                {
                    "end": 90,
                    "normalized_text": "BIOCORP",
                    "probability": 0.4686,
                    "start": 84,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 6,
                    "start": 0,
                    "tag": "PRESS"
                }
            ]
        },
        "id": "1665587416218976258",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 14362,
            "like_count": 26,
            "quote_count": 2,
            "reply_count": 5,
            "retweet_count": 4
        },
        "text": "#PRESS Novo Nordisk enters exclusive negotiations to acquire a controlling stake in BIOCORP, to be followed by a tender offer on all remaining shares."
    }
}